(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

AEYE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

AEYE

ST13

US500000088442596

Classe

9, 42, 44

Pedido

88442596

Registro

6060704

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

52

Atualização mais recente

10/05/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 42, 44

Data de depósito

22/05/2019

Data de registro

19/05/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

09/05/2026

Última transação

10/05/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

701

Cadastro oficial

Supplemental Register

Fundamento do pedido

Intent to use

Primeiro uso

01/05/2017

Primeiro uso no comércio

01/05/2017

Código do desenho

4

Tipo de titular

16

Localização do titular

New York, NY, US

Examinador

CLARK, ROBERT C

Localização atual

Historical data usage

Titulares e representantes

Titulares

AEYE Health LLC

Representantes

Mark I. Koffsky Koffsky Schwalb LLC

Classificação técnica

Classes Nice

Classe 9Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Downloadable medical software for performing medical diagnosis using machine learning; Downloadable medical software for performing retinal screening; Downloadable medical software for screening and analyzing of fundus images; Downloadable medical software for diagnosing medical conditions of patients; Downloadable medical software for use in a retinal camera for analyzing retinal images; Downloadable medical software for diagnosis of medical conditions based on images; Downloadable medical software for controlling and managing patient medical information; Recorded medical software for performing medical diagnosis using machine learning; Recorded medical software for performing retinal screening; Recorded medical software for screening and analyzing of fundus images; Recorded medical software for diagnosing medical conditions of patients; Recorded medical software for use in a retinal camera for analyzing retinal images; Recorded medical software for diagnosis of medical conditions based on images; Recorded medical software for controlling and managing patient medical information

Classe 42

Providing temporary use of on-line non-downloadable software for medical diagnosis; Providing temporary use of on-line non-downloadable software for retinal screening; Providing temporary use of on-line non-downloadable software for screening and analyzing of fundus images; Providing temporary use of on-line non-downloadable software for diagnosing medical conditions of patients; Providing temporary use of on-line non-downloadable software for controlling and managing patient medical information; Software as a service (SAAS) services featuring software for diagnosis of medical conditions based on images; Software as a service (SAAS) services featuring software for medical diagnosis; Software as a service (SAAS) services featuring software for machine learning-based medical diagnosis; Software as a service (SAAS) services featuring software for performing retinal screening; Software as a service (SAAS) services featuring software for controlling and managing patient medical information

Classe 44

Medical counseling; Medical counseling relating to disease risk; Medical screening; Medical testing for diagnostic or treatment purposes; Providing medical information; Providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms

Publicações

Histórico de despachos e eventos da marca no USPTO.

52 publicações encontradas

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

09/05/2026

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

09/05/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/05/2026

ES8R

TEAS SECTION 8 RECEIVED

30/12/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

19/05/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/02/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/02/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/02/2021

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

19/05/2020

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/04/2020

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

03/04/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

24/03/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

24/03/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

23/03/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

23/03/2020

GNRT

NON-FINAL ACTION E-MAILED

23/03/2020

CNRT

NON-FINAL ACTION WRITTEN

23/03/2020

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

23/03/2020

ALIE

ASSIGNED TO LIE

09/03/2020

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

03/03/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/03/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/03/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/03/2020

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

29/02/2020

IUAA

USE AMENDMENT ACCEPTED

28/02/2020

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

28/02/2020

RFTP

REMOVED FROM TEAS PLUS

28/02/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

21/02/2020

GNRT

NON-FINAL ACTION E-MAILED

21/02/2020

CNRT

NON-FINAL ACTION WRITTEN

21/02/2020

IUAF

USE AMENDMENT FILED

20/02/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

20/02/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

20/02/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

20/02/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

20/02/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

20/02/2020

EAAU

TEAS AMENDMENT OF USE RECEIVED

20/02/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

20/02/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

20/02/2020

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

20/02/2020

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

23/09/2019

GNFR

FINAL REFUSAL E-MAILED

23/09/2019

CNFR

FINAL REFUSAL WRITTEN

23/09/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

18/09/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/09/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

18/09/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/08/2019

GNRT

NON-FINAL ACTION E-MAILED

09/08/2019

CNRT

NON-FINAL ACTION WRITTEN

09/08/2019

DOCK

ASSIGNED TO EXAMINER

08/08/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/06/2019

NWAP

NEW APPLICATION ENTERED

25/05/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace AEYE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.